Duration of Exercise Program in Interstitial Lung Diseases.

• Sponsor: Izmir Katip Celebi University (Other)
• Overall Status: Completed
• CT.gov ID: NCT03302702
• Collaborator: (none)
• Enrollment: 14
• Arm: 1
• Actual Duration (Months): 24

Study Details

Study Description

Brief Summary

We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.

Condition or Disease	Intervention/Treatment	Phase
Interstitial Lung Disease	Other: Exercise program	N/A

Detailed Description

Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown.

We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD.

A total of 14 patients with ILD referred to our PR unit [11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.

Study Design

• Study Type: Interventional
• Actual Enrollment: 14 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: A Comparison Trial of Eight Weeks Versus Twelve Weeks of Exercise Program in Interstitial Lung Diseases.
• Actual Study Start Date: Jan 1, 2014
• Actual Primary Completion Date: Jan 1, 2016
• Actual Study Completion Date: Jan 1, 2016

Arms and Interventions

Arm	Intervention/Treatment
Other: Exercise program Treatment group	Other: Exercise program; Exercise program including breathing control, pursed-lip breathing, diaphragmatic and thoracic breathing, aerobic and strengthening training

Outcome Measures

Primary Outcome Measures

1. Six minute walk test [6 minute]

   It was performed in a 30-meter long corridor in accordance with American Thoracic Society criteria

Secondary Outcome Measures

1. mMRC [5 minutes]

   It was used for dyspnea that patients felt during their daily activities.

2. Pulmonary Function Test [20 minutes]

   It was used for assessment of lung functions

3. SGRQ [30 minutes]

   A disease-specific quality of life scale

4. SF-36 Health Survey [30 minutes]

   A health related quality of life scale

5. Hospital Anxiety and Depression Inventory [20 minutes]

   It was used for assessment of anxiety and depression

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Completed the 12 week exercise program

• Diagnosed with ILD

Exclusion Criteria:

• Not completed 12 week exercise program

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Izmir Katip Celebi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Ilknur Naz, Asst. Prof, Izmir Katip Celebi University
• ClinicalTrials.gov Identifier: NCT03302702
• Other Study ID Numbers: IKC4
• First Posted: Oct 5, 2017
• Last Update Posted: Oct 5, 2017
• Last Verified: Oct 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Ilknur Naz, Asst. Prof, Izmir Katip Celebi University: exercise; duration
• Additional relevant MeSH terms: Lung Diseases; Lung Diseases, Interstitial

Study Results

No Results Posted as of Oct 5, 2017